Hematology Reagent MTS™ A / B Monoclonal Grouping CLIA Non-Waived For Ortho Vision / Ortho Vision Max / ID-MTS Workstation / Ortho ProVue Analyzers 100 Tests

Name: Hematology Reagent
Brand: MTS™

MTS CARD, AB MONO GROUP (100/CS)

McKesson #

1090986

Manufacturer #

MTS080017

Brand

MTS™

Manufacturer

Ortho Clinical Diagnostics

Country of Origin

United States

Application

Hematology Reagent

CLIA Classification

CLIA Moderate Complexity for Routine Blood Typing (Information Only) / CLIA High Complexity for Compatibility Testing

CLIA Classified

CLIA Non-Waived

For Use With

For Ortho Vision / Ortho Vision Max / ID-MTS Workstation / Ortho ProVue Analyzers

Form

Liquid

Number of Tests

100 Tests

Product Dating

McKesson Acceptable Dating: we will ship >= 60 days

Sample Type

Whole Blood / Serum / Plasma Sample

Specialty

Hematology

Test Category

Blood Bank

Test Format

Gel Card

Test Name

A / B Monoclonal Grouping

Test Type

Blood Grouping Test

UNSPSC Code

41116101

MTS™ Buffered Gel Card can be used in ABO Serum Grouping as well as direct agglutination i.e., cold and warm antibody detection
Delivered with gel-filled microtubes infused with pre-measured reagents
Gel testing is easy to learn, use, and teach: the ideal technology for all shifts and all levels of blood banking experience
Eliminates washing, shaking, and the need to add control cells
Well-balanced sensitivity and specificity means less time and fewer resources spent on clinically unimportant antibodies
Contains: (100) Buffered Gel Cards each Containing Anti-A (Murine Monoclonal) and Anti-B (Murine Monoclonal)
The ID-Micro Typing System™ can be easily automated with ID-MTS™ Workstation or Ortho ProVue™ Analyzer
HIGH Complexity designation – All test systems, assays or examinations used in compatibility testing when performed to determine donor/recipient compatibility: recipient & donor ABO group/D (Rho) type/antigen typing, direct antiglobulin test, tests for unexpected antibody detection & identification, & crossmatch procedures are HIGH Complexity. See: Federal Register notice, February 28, 1992 [57 FR 7245]
Rx only